Clinical Diagnostics: Key market research findings
- Surge in demand for clinical molecular diagnostic methods
- Growing popularity of POC testing products
Technavio has added a new market research report on the clinical diagnostics market in APAC, to its diagnostics market. The clinical diagnostics market in APAC is expected to grow at a CAGR of around 13% between 2015 and 2019 due to the easy accessibility of diagnostic tools and their convenient usage. Countries like Australia, China, India, Japan, and South Korea are the major contributors to the market in APAC.
The new industry research report from Technavio discusses in detail the key drivers and trends responsible for growth, as well as the segments with the maximum growth potential.
“In recent years, the clinical molecular diagnostic methods like DNA microarrays have gained wide prominence in the diagnosis of life-threatening diseases such as cancers, tuberculosis, Alzheimer’s disease, cardiovascular diseases, and influenza. These methods increase the outcome accuracy and lower the turnaround time of screening and detection procedures. Molecular diagnostic tools easily detect the amount of tumor proteins and nucleic acids in cancer patients, thereby ensuring cancer recognition in early stages,” says Imran Mushtaq, Lead Analyst, Healthcare, Technavio Research.
The increased demand for point-of-care (POC) devices in molecular diagnosis and immunodiagnosis is encouraging this market’s growth. The POC testing products can be used at the patient’s bedside, leading to fewer follow-up visits. These systems minimise the waiting time of the test results and improve healthcare accessibility. Also, POC testing has augmented the demand for home diagnostics devices pregnancy tests, fecal occult blood assays, ovulation predictors, and blood glucose monitors.
The leading vendors in the clinical diagnostics market in APAC include Abbott, Biomerieux, Beckman Coulter Diagnostics, Roche, and Qiagen. This market is dominated by large vendors, and offers tremendous growth opportunities to the vendors. Since the market in APAC is rapidly growing, the establishment of industries and headquarters in this region will foster the growth opportunities for the vendors.
A more detailed analysis is available in the Technavio report, Clinical Diagnostics Market in APAC – Market Analysis 2015-2019.
We can customize reports by other regions and specific segments upon request.
Other Related Reports:
- Global TB Diagnostic Market 2015-2019
- Global POC Diagnostics Market 2015-2019
- Global Oncology Molecular Diagnostics Market 2015-2019
Further Reading:
